Pathology results are typically the gold standard for decision making in thyroid cancer; therefore, the main contribution of FNAB-Tg assessment is in determining the best balance between necessary and unnecessary surgery in metastatic patients with a negative or nondiagnostic pathological result. This evidence concerns the gene TG and thyroid cancer.